STOCK TITAN

GeneDx (WGS) CFO logs RSU vesting and tax-cover share sales

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

GeneDx Holdings Corp. chief financial officer Kevin Feeley reported an RSU vesting and related share sales to cover taxes. On June 16, 2026, 7,197 restricted stock units converted into an equal number of Class A Common shares for no cash consideration.

To fund tax withholding on this vesting, he sold a total of 3,729 Class A Common shares in open-market transactions at weighted-average prices between about $59 and $62 per share. After these sales, he beneficially owned 39,954 shares, plus RSUs covering up to 82,043 shares and options for up to 25,906 shares, all vesting under their existing terms.

Positive

  • None.

Negative

  • None.
Insider Feeley Kevin
Role CHIEF FINANCIAL OFFICER
Sold 3,729 shs ($227K)
Type Security Shares Price Value
Exercise Restricted Stock Unit 7,197 $0.00 --
Exercise Class A Common Stock 7,197 $0.00 --
Sale Class A Common Stock 760 $59.7543 $45K
Sale Class A Common Stock 2,106 $60.8291 $128K
Sale Class A Common Stock 863 $61.5035 $53K
Holdings After Transaction: Restricted Stock Unit — 21,590 shares (Direct, null); Class A Common Stock — 43,683 shares (Direct, null)
Footnotes (1)
  1. Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.26 to $60.24 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 and 5 of this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.40 to $61.35 per share, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.44 to $61.69 per share, inclusive. Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 39,954 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate 82,043 shares of the Issuer's Class A Common Stock and options to purchase up to an aggregate 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms. 6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date.
Shares sold 3,729 shares Open-market sales on June 16, 2026 to cover RSU taxes
RSUs vested 7,197 units RSUs converting into Class A Common Stock on June 16, 2026
Weighted-average sale prices $59.26–$61.69 per share Price ranges for multiple sale transactions on June 16, 2026
Shares owned after transactions 39,954 shares Class A Common Stock beneficially owned following tax-cover sales
RSUs outstanding 82,043 units Contingent rights to receive Class A Common Stock after reported sale
Stock options outstanding 25,906 options Options to purchase Class A Common Stock, vesting per their terms
Quarterly vesting rate 6.25% Portion of the referenced RSU award vesting each quarter
restricted stock unit ("RSU") financial
"Each restricted stock unit ("RSU") represents a contingent right to receive 1 share..."
sell to cover financial
"The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction..."
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
weighted average price financial
"The price reported in Column 4 is a weighted average price. These shares were sold..."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
beneficially owned financial
"in addition to the 39,954 shares of Class A Common Stock beneficially owned by the Reporting Person..."
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
options to purchase financial
"and options to purchase up to an aggregate 25,906 shares of Class A Common Stock..."
A legal right, usually in the form of a contract, that lets someone buy a specific asset—most often shares—at a set price within a fixed time period. Think of it like a reservation or coupon that guarantees today’s price for a future purchase; investors watch these because exercising the options can change how many shares exist, affect company ownership, and create potential gains or dilution for existing shareholders.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Feeley Kevin

(Last)(First)(Middle)
C/O GENEDX HOLDINGS CORP.
333 LUDLOW ST., NORTH TOWER, 6TH FLOOR

(Street)
STAMFORD CONNECTICUT 06902

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
GeneDx Holdings Corp. [ WGS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CHIEF FINANCIAL OFFICER
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock06/16/2026M7,197A$0(1)43,683D
Class A Common Stock06/16/2026S(2)760D$59.7543(3)42,923D
Class A Common Stock06/16/2026S(2)2,106D$60.8291(4)40,817D
Class A Common Stock06/16/2026S(2)863D$61.5035(5)39,954(6)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(1)06/16/2026M7,197 (7) (7)Class A Common Stock7,197$021,590D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
2. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.26 to $60.24 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 and 5 of this Form 4.
4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.40 to $61.35 per share, inclusive.
5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.44 to $61.69 per share, inclusive.
6. Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 39,954 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate 82,043 shares of the Issuer's Class A Common Stock and options to purchase up to an aggregate 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms.
7. 6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date.
/s/ Bridget Brown, Attorney-in-Fact06/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did GeneDx (WGS) CFO Kevin Feeley report in this Form 4?

Kevin Feeley reported a vesting of restricted stock units and related share sales to cover taxes. 7,197 RSUs converted into Class A Common shares, and some of those shares were sold in the market solely to satisfy associated withholding obligations.

How many GeneDx (WGS) shares did the CFO sell and at what prices?

Feeley sold a total of 3,729 Class A Common shares in three open-market transactions. The weighted-average sale prices ranged from about $59.26 to $61.69 per share, reflecting multiple trades within those ranges as disclosed in the filing’s price footnotes.

Why did the GeneDx (WGS) CFO sell shares in this transaction?

The shares were sold solely to cover tax withholding obligations triggered by RSU vesting and settlement. The filing specifies this was a “sell to cover” transaction, meaning the disposition was non-discretionary and executed to fund required tax payments, not an elective share sale.

How many GeneDx (WGS) shares does the CFO own after these transactions?

Following the tax-cover sales, Feeley beneficially owned 39,954 shares of Class A Common Stock. This figure reflects his direct holdings after the reported transactions, separate from additional RSUs and stock options that may convert into shares as they vest over time.

What RSU and option awards does the GeneDx (WGS) CFO still hold?

After the reported events, Feeley held RSUs for up to 82,043 shares and options for up to 25,906 shares. These awards vest under their existing schedules, with 6.25% of a referenced RSU award vesting quarterly, contingent on continued service with the company.

How do the GeneDx (WGS) CFO’s RSUs convert into common stock?

Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock at settlement for no cash consideration. The RSUs either vest according to their schedules, such as quarterly vesting, or are cancelled if vesting conditions such as continued service are not met.